DudeDiligence.

Zevra Therapeutics, Inc

ZVRANASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$5,990,923

11 notices · 601,824 sh

Reported ·

$2,520,797

13 sales · 0 buys

The two figures cover different periods.

12 of 13 reported sales carry the 10b5-1 box. Together they are 0.41% of the shares on issue.

PLANNED · FORM 144REPORTED · FORM 4D2025J2026FMAMJJASON2026-10-12: NEIL F MCFARLANE, Form 1442026-08-14: RAHSAAN THOMPSON, Form 1442026-07-08: JOHN BODE, Form 1442026-05-11: Rahsaan Thompson, Form 1442026-03-16: RAYMOND L CLIFTON, Form 1442026-02-02: NEIL F MCFARLANE, Form 1442026-01-30: TIMOTHY SANGIOVANNI, Form 1442026-01-30: R LaDuane Clifton, Form 1442026-01-30: RAHSAAN THOMPSON, Form 1442026-01-30: JOSHUA SCHAFER, Form 1442026-01-30: ADRIAN QUARTEL, Form 1442026-01-30: Sangiovanni Timothy J., sold2026-01-30: Thompson Rahsaan, sold2026-01-30: Quartel Adrian W, sold2026-01-30: Schafer Joshua, sold2026-02-02: McFarlane Neil F., sold2026-02-03: Sangiovanni Timothy J., sold2026-02-03: Schafer Joshua, sold2026-02-09: McFarlane Neil F., sold2026-05-11: Thompson Rahsaan, sold2026-06-22: Thompson Rahsaan, sold2026-08-10: Watton Corey Michael, sold2026-08-14: Thompson Rahsaan, sold2026-10-12: McFarlane Neil F., sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-12NEIL F MCFARLANE, President and CEO$227,800
20,000 shplan 2026-03-25144 ↗
Form 4, 2026-10-13: sold 20,000 at $11.25 Form 4 ↗
2026-08-14RAHSAAN THOMPSON, Chief Legal & Compliance$477,006
42,666 shplan 2026-05-15144 ↗
Form 4, 2026-08-17: sold 42,666 at $11.13 Form 4 ↗
2026-07-08JOHN BODE, Director$156,163
10,516 shno plan dateno Form 4 on file144 ↗
2026-05-11Rahsaan Thompson, Chief Legal & Compliance$404,587
36,351 shplan 2026-01-08144 ↗
Form 4, 2026-05-13: sold 1,794 at $11.30 Form 4 ↗
2026-03-16RAYMOND L CLIFTON, Officer$3,409,374
345,428 shno plan dateno Form 4 on file144 ↗
2026-02-02NEIL F MCFARLANE, President and CEO$950,625
105,625 shplan 2025-03-21144 ↗
Form 4, 2026-02-02: sold 91,000 at $9.38 Form 4 ↗
2026-01-30TIMOTHY SANGIOVANNI, SVP, Finance & Corp Controller$42,085
4,750 shplan 2025-03-27144 ↗
Form 4, 2026-02-02: sold 1,750 at $8.82 Form 4 ↗
2026-01-30R LaDuane Clifton, Former CFO & Treasurer$124,040
14,000 shplan 2025-03-27no Form 4 on file144 ↗
2026-01-30RAHSAAN THOMPSON, Chief Legal & Compliance$36,149
4,080 shplan 2025-03-27144 ↗
Form 4, 2026-02-02: sold 4,080 at $8.83 Form 4 ↗
2026-01-30JOSHUA SCHAFER, CCO$122,933
13,875 shplan 2025-03-27144 ↗
Form 4, 2026-02-02: sold 3,375 at $8.83 Form 4 ↗
2026-01-30ADRIAN QUARTEL, Chief Medical Officer$40,162
4,533 shplan 2025-03-26144 ↗
Form 4, 2026-02-02: sold 4,533 at $8.83 Form 4 ↗